They also found that both NUDT19 overexpression and mTORC1 activator MYH1485 could reverse the inhibitory effect of LINC00958 silencing on the proliferation, migration, and EMT process of HCC (Lan et al., 2021). The gene discussed is LINC00958; the disease is hepatocellular carcinoma.